Moroğlu Arseven is a full-service law firm with broadly demonstrated expertise and experience in all aspects of business law. Established in 2000, the firm combines a new generation of experienced international business lawyers and acclaimed counsels who have academic, judicial and practical experience in private law. Its dynamic and dedicated team is able to analyse the legal framework and provide flexible solutions for clients doing business in Turkey. The firm serves local clients in international markets and international clients in Turkey. Clients appreciate the firm’s responsive, clear and concise answers to legal questions, as well as its knowledge of their business goals, usually based on long relationships.
The firm represents and serves a diverse clientele, in a wide range of industries. In-depth sector knowledge ensures seamless service across practice areas, enabling Moroglu Arseven to meet all of a client’s legal needs in Turkey. Key areas include pharmaceuticals, life sciences, manufacturing, retail, energy, banking and financial markets, construction, real estate, TMT and sports.
Moroğlu Arseven is known in Turkey as a detail oriented, well-connected, hands-on and concentrated law firm, as well as being expert at handling complex tasks, whether these tasks are related to transactions, disputes or settlements.
The firm has a dynamic and dedicated team of more than 50 lawyers, capable of communicating in English, French, German, and Turkish.
Istanbul’s First Instance IP Court recently dismissed a negative declaratory action (the “Case”) against our client citing the plaintiff’s lack of standing because the pharmaceutical at issue was unlicensed as of the when the action was started. The ruling is noteworthy because it appears to confirm the precedential force of similar Court of Appeal decisions. For pharmaceuticals in particular, negative declaratory relief is considered as an effective market-clearing tool. Anyone with an interest in a pharmaceutical product sufficient to…
The shockwaves from the UK’s exit from the European Union have resounded across the continent, including in Turkey, where the country’s pharmaceutical and medical devices regulator has had to adjust its guidance on CE-mark certified devices. Leading lawyers from top Turkish law firm and PharmaBoardroom legal partner Moroğlu Arseven explain the current situation. CE Certificate Requirement in Turkey The Regulation on CE Marking, published in the Official Gazette on, and effective as of, 23 February 2012 (the “Regulation”) governs…
The COVID-19 pandemic continues to spread rapidly across the globe amid critical supply shortages of medical devices and medicines. The rapid spread of the virus, on the one hand, threatens supply chains and causes shortages, on the other hand, it also strengthens global solidarity. Brands from different sectors make an effort towards helping in the fight against the pandemic. Fashion brands are manufacturing masks, luxury cosmetic brands are supporting disinfectant manufactures, the entrepreneur ecosystem swept into seeking alternative ways to…